Nuwellis, founded with a mission to enhance the quality of life for patients suffering from heart failure and fluid overload, focuses on innovative fluid management solutions. The company's flagship product, the Aquadex FlexFlow® System, offers a novel therapy for hypervolemia, particularly for patients who do not find relief from diuretic medications. Nuwellis aims to restore fluid balance and renew hope for patients, placing them at the center of their operations.
Notable figures affiliated with Nuwellis include key medical professionals and investors dedicated to advancing healthcare technologies. The company has achieved significant milestones in patient outcomes, with testimonials highlighting the life-saving impact of the Aquadex system. Through its innovative approach, Nuwellis has made a substantial impact on the treatment of heart-related conditions, improving patient care and quality of life.
